Nanexa AB (publ) (STO:NANEXA)
2.500
+0.055 (2.25%)
Jun 17, 2025, 11:59 AM CET
Nanexa AB Revenue
Nanexa AB had revenue of 7.65M SEK in the quarter ending March 31, 2025, a decrease of -45.49%. This brings the company's revenue in the last twelve months to 40.31M, down -32.52% year-over-year. In the year 2024, Nanexa AB had annual revenue of 46.69M, down -21.07%.
Revenue (ttm)
40.31M
Revenue Growth
-32.52%
P/S Ratio
9.52
Revenue / Employee
3.10M
Employees
13
Market Cap
383.64M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 46.69M | -12.47M | -21.07% |
Dec 31, 2023 | 59.16M | 31.99M | 117.72% |
Dec 31, 2022 | 27.17M | 9.16M | 50.87% |
Dec 31, 2021 | 18.01M | -2.85M | -13.66% |
Dec 31, 2020 | 20.86M | 12.13M | 138.93% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Swedish Orphan Biovitrum AB | 26.24B |
Sectra AB | 3.31B |
Getinge AB | 35.57B |
Asker Healthcare Group AB | 15.57B |
Medicover AB | 23.56B |
Camurus AB | 2.04B |
AddLife AB | 10.42B |
Vimian Group AB | 4.24B |